@article{392cc8c8954e456ea79f02b5f6b1b9c0,
title = "Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting",
keywords = "HIV, tenofovir disoproxil fumarate, tenofovir alafenamide, dyslipidemia, cholesterol, lipid-lowering effect, STATIN THERAPY, DOUBLE-BLIND, MYOCARDIAL-INFARCTION, LDL CHOLESTEROL, ADVERSE EVENTS, EZETIMIBE, EFFICACY, RISK, SAFETY, 3142 Public health care science, environmental and occupational health, 3121 Internal medicine",
author = "Kauppinen, {Kai Juhani} and Pia Kivel{\"a} and Jussi Sutinen",
year = "2019",
month = dec,
doi = "10.1089/apc.2019.0236",
language = "English",
volume = "33",
pages = "500--506",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert",
number = "12",
}